The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
PO Box 629
Narellan, NSW 2567 Australia
Sarcoidosis and Lyme Disease Support Group Australia is a voluntary organization established for sufferers, families and caregivers affected by sarcoidosis and Lyme disease. Sarcoidosis and Lyme Disease Support Group aims to bring fellow sufferers together to support each other and their families; provide and share information and experiences, acting as a forum to help those affected to understand the condition; support the medical profession in the early diagnosis and treatment of those with these diseases; support research on these diseases; and heighten awareness of these diseases in Australia. Sarcoidosis is a multisystem disorder characterized by the abnormal formation of inflammatory masses or nodules (granulomas) consisting of certain granular white blood cells (modified macrophages or epithelioid cells) in certain organs of the body. The granulomas that are formed are thought to alter the normal structure of and, potentially, the normal functions of, the affected organ(s), causing symptoms associated with the particular body system(s) in question. Lyme disease is an infectious disease caused by the spirochete bacterium Borrelia burgdorferi. Some studies have been conducted that suggest the possible connection between having Lyme disease and developing sarcoidosis.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.